Discrepancy in Neurologic Outcomes Following Aneurysmal Subarachnoid Hemorrhage as a Function of Socioeconomic Class.

World neurosurgery 2020 Vol.138() p. e787-e794

Strickland BA, Mert M, Ravina K, Chartrain A, Rennert RC, Bakhsheshian J, Shahrestani S, Jackanich A, Amar A, Mack W, Russin JJ, Giannotta SL

Abstract

[OBJECTIVE] To investigate potential health care discrepancies in patients with ruptured cerebral aneurysms undergoing microsurgical intervention.

[METHODS] We retrospectively reviewed patients with ruptured intracranial aneurysms treated at our tertiary referral university hospital (UH) and safety net county hospital (CH) from 2010 to 2015. We identified 73 UH patients and 58 CH patients.

[RESULTS] UH patients had shorter time duration between rupture and intervention (P < 0.001) and higher rates of intubation on admission (P = 0.01). Verapamil was more frequently used for clinical vasospasm in UH patients, at 0.13 (95% confidence interval [CI], 0.09-0.18) treatments per patient per day versus 0.077 (95% CI, 0.047-0.12) treatments per patient per day in CH patients, though there was no difference in delayed cerebral ischemia (P = 0.15). The majority of the CH cohort was uninsured (26.3%; UH 0%) or had Medicaid (59.7%; UH 35.2%) (P < 0.001). The UH had more dispositions to home or rehabilitation centers than the CH (82% vs. 67.3%; P = 0.04). After adjusting for disease severity, hospital stay, and insurance status, CH patients were 3.73 (95% CI, 1.25-12.14) times more likely to be discharged with a poor modified Rankin Scale score and 3.08 (95% CI, 1.04-9.61) times more likely to be discharged with a poor Glasgow Outcome Scale score compared with UH patients (P = 0.02 and P = 0.04, respectively).

[CONCLUSIONS] Limited resource availability in a safety net hospital system could be a major driving force behind the health care discrepancy identified in our ruptured cerebral aneurysm population. Reallocation of resources to supplement advanced inpatient acute care technologies and, more importantly, post-acute care environments can narrow the outcomes gap.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 cerebral scispacy 1
합병증 Aneurysmal Subarachnoid scispacy 1
합병증 intracranial scispacy 1
약물 Verapamil C0042523
verapamil
scispacy 1
약물 [OBJECTIVE] scispacy 1
약물 [RESULTS] UH scispacy 1
약물 [CONCLUSIONS] Limited scispacy 1
질환 Aneurysmal Subarachnoid Hemorrhage C0751530
Subarachnoid Hemorrhage, Aneurysmal
scispacy 1
질환 ruptured cerebral aneurysms scispacy 1
질환 ruptured intracranial aneurysms scispacy 1
질환 rupture C3203359
Rupture
scispacy 1
질환 vasospasm C0085616
Vasospasm
scispacy 1
질환 cerebral ischemia C0007785
Cerebral Infarction
scispacy 1
질환 cerebral aneurysm C0917996
Cerebral Aneurysm
scispacy 1
질환 disease scispacy 1
기타 Class scispacy 1
기타 patients scispacy 1
기타 cerebral scispacy 1
기타 patient scispacy 1
기타 Medicaid scispacy 1

MeSH Terms

Female; Health Services Accessibility; Humans; Male; Microsurgery; Middle Aged; Retrospective Studies; Safety-net Providers; Socioeconomic Factors; Subarachnoid Hemorrhage; Tertiary Care Centers; Trauma Severity Indices; Treatment Outcome; Vasodilator Agents; Vasospasm, Intracranial; Verapamil